Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,465,562 papers from all fields of science
Search
Sign In
Create Free Account
RP23 gene
Known as:
RETINITIS PIGMENTOSA 23
, RP23
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Decreased night vision
MAPRE2 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Deep intronic mutation in OFD1, identified by targeted genomic next-generation sequencing, causes a severe form of X-linked retinitis pigmentosa (RP23).
T. Webb
,
David A. Parfitt
,
+13 authors
A. Hardcastle
Human Molecular Genetics
2012
Corpus ID: 2631236
X-linked retinitis pigmentosa (XLRP) is genetically heterogeneous with two causative genes identified, RPGR and RP2. We…
Expand
Highly Cited
2007
Highly Cited
2007
Defining the expression pattern of the LGI1 gene in BAC transgenic mice
K. Head
,
Shiaoching Gong
,
+9 authors
J. Cowell
Mammalian Genome
2007
Corpus ID: 24343183
The LGI1 gene has been implicated in the development of epilepsy and the invasion phenotype of glial cells. Controversy over the…
Expand
2000
2000
Evidence for a new locus for X-linked retinitis pigmentosa (RP23).
A. Hardcastle
,
D. Thiselton
,
+4 authors
S. Bhattacharya
Investigative Ophthalmology and Visual Science
2000
Corpus ID: 25773512
PURPOSE X-linked retinitis pigmentosa (XLRP) is a degenerative disease of the retina characterized in the early stages of disease…
Expand
1983
1983
Establishment of lymphoblastoid cell lines from Marek's disease primary tumors.
X. Liu
,
L. Lee
,
J. M. Sharma
,
K. Nazerian
Poultry Science
1983
Corpus ID: 3624836
Seven lymphoblastoid cell lines were developed from 15 Marek's disease primary lymphomas treated to remove adherent cells (46.7…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE